Biomarin Pharmaceutical ( BMRN )
How has the company changed?
Name Type Last Updated
How Did Biomarin Pharmaceutical [BMRN] Fare in 2018 and What Can We Expect In 2019? Annual 2019-06-02


How does it make money?
Name Type Last Updated
What Are The Key Drivers Of Biomarin Pharmaceutical's Expenses? Annual 2019-10-04


Income Statement Data: Historicals & Forecasts
Name Type Last Updated
Net Product Revenues: Total Revenues 2014-2020 Annual 2019-07-08
Royalty And Other Revenues: Total Revenues 2014-2020 Annual 2019-07-08
Revenues: Total Revenues 2014-2020 Annual 2019-07-08
Revenues: Collaborative Agreement Revenues 2014-2020 Annual 2019-07-08
Operating Expenses: Cost Of Sales 2014-2020 Annual 2019-07-08
Operating Expenses: Research And Development 2014-2020 Annual 2019-07-08
Operating Expenses: Selling General And Administrative 2014-2020 Annual 2019-07-08
Other Income 2014-2020 Annual 2019-07-08
Net Income Growth 2015-2020 Annual 2019-07-08
Net Income Margin 2014-2020 Annual 2019-07-08
Operating Expenses: Impairment Of Intangible Asset 2014-2020 Annual 2019-07-08
Loss Before Income Taxes 2014-2020 Annual 2019-07-08
Provision For Income Taxes 2014-2020 Annual 2019-07-08
Change in EPS 2015-2020 Annual 2019-07-08
Earnings Per Share: Basic 2014-2020 Annual 2019-07-08
Earnings Per Share: Diluted 2014-2020 Annual 2019-07-08
Interest Income 2014-2020 Annual 2019-07-08
Weighted Average Common Shares Outstanding Basic 2014-2020 Annual 2019-07-08
Weighted Average Common Shares Outstanding Basic And Diluted 2014-2020 Annual 2019-07-08
Interest Expense 2014-2020 Annual 2019-07-08
Weighted Average Common Shares Outstanding Diluted 2014-2020 Annual 2019-07-08
EBIT % of Sales 2014-2020 Annual 2019-07-08
R&D % of Sales 2014-2020 Annual 2019-07-08
SG&A % of Sales 2014-2020 Annual 2019-07-08
EBT Growth 2015-2020 Annual 2019-07-08
Revenue Growth 2015-2020 Annual 2019-07-08
Tax Rate 2014-2020 Annual 2019-07-08
Change in EBT 2015-2020 Annual 2019-07-08
Change in Total Expense 2015-2020 Annual 2019-07-08
Equity In The Loss Of Biomarin/genzyme Llc 2014-2020 Annual 2019-07-08
Loss From Operations 2014-2020 Annual 2019-07-08
Net Loss 2014-2020 Annual 2019-07-08
Net Loss Per Share Basic And Diluted 2014-2020 Annual 2019-07-08
Operating Expenses: Gain On Sale Of Intangible Asset 2014-2020 Annual 2019-07-08
Operating Expenses: Intangible Asset Amortization And Contingent Consideration 2014-2020 Annual 2019-07-08
Operating Expenses: Total Operating Expenses 2014-2020 Annual 2019-07-08
Total Expense 2014-2020 Annual 2019-07-08
Debt Conversion Expense 2014-2020 Annual 2019-07-08